The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study
Open accessAbstract
BACKGROUND: Antidepressants are commonly prescribed medications in the elderly, but their relationship with incident mild cognitive impairment (MCI) and probable dementia is unknown. METHODS: The study cohort included 6,998 cognitively healthy, postmenopausal women, aged 65-79 years, who were enrolled in a hormone therapy clinical trial and had baseline depressive symptoms and antidepressant use history assessments at enrollment, and at least one postbaseline cognitive measurement. Participants were followed annually and the follow-up averaged 7.5 years for MCI and probable dementia outcomes. A central adjudication committee classified the presence of MCI and probable dementia based on extensive neuropsychiatric examination. RESULTS: Three hundred and eighty-three (5%) women were on antidepressants at baseline. Antidepressant use was associated with a 70% increased risk of MCI, after controlling for potential covariates including the degree of depressive symptom severity. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) were both associated with MCI (SSRIs: hazard ratios (HR), 1.78 [95% CI, 1.01-3.13]; TCAs: HR, 1.78 [95% CI, 0.99-3.21]). Depressed users (HR, 2.44 [95% CI, 1.24-4.80]), non-depressed users (HR, 1.79 [95% CI, 1.13-2.85]), and depressed non-users (HR, 1.62 [95% CI, 1.13-2.32]) had increased risk of incident MCI. Similarly, all three groups had increased risk of either MCI or dementia, relative to the control cohort. CONCLUSIONS: Antidepressant use and different levels of depression severity were associated with subsequent cognitive impairment in a large cohort of postmenopausal women. Future research should examine the role of antidepressants in the depression-dementia relationship and determine if antidepressants can prevent incident MCI and dementia in individuals with late-life depression subtypes with different levels of severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Peakman et al. (2020) and Goveas et al. (2012) found that antidepressant use was associated with dementia risk (adjusted HR 1.32 [95% CI 1.01-1.74] and 1.69 [95% CI 1.21-2.35], respectively), but no association was found for SSRIs (adjusted HR 1.07 [95% CI 0.91-1.25] and 1.50 [95% CI 0.89-2.53], respectively).
“Nonetheless, Peakman et al., 2020 [33] and Goveas et al., 2012 [34] pointed out that even though antidepressant use was found to be associated with the risk of dementia (adjusted hazard ratio [HR]: 1.32 [95% CI: 1.01–1.74] and 1.69 [95% CI: 1.21–2.35], respectively), an association was not found for SSRIs (adjusted HR: 1.07 [95% CI: 0.91–1.25] and 1.50 [95% CI: 0.89–2.53], respectively).”
From Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study (2023) · cites this paper as [34]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Steffens, D. C., Otey, E., Alexopoulos, G. S., Butters, M. A., Cuthbert, B., Ganguli, M., Geda, Y. E., Hendrie, H. C., Krishnan, R. R., Kumar, A., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.130 · Cited by 274
NELSON, R., GUO, Z., HALAGAPPA, V, PEARSON, M., GRAY, A., MATSUOKA, Y., BROWN, M., MARTIN, B., IYUN, T., & MAUDSLEY, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.037 · Cited by 173
Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171
Patterns of Mild Cognitive Impairment After Treatment of Depression in the Elderly
Bhalla, R. K., Butters, M. A., Becker, J. T., Houck, P. R., Snitz, B. E., Lopez, O. L., Aizenstein, H. J., Raina, K. D., DeKosky, S. T., & Reynolds, C. F. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318190b8d8 · Cited by 105
Flagged first, then by citations
Research works printed but not linked: 28
- Aboukhatwa, 2010, Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease, Molecular Neurodegenertion, 5, 10, 10.1186/1750-1326-5-10 · DOI
- Almeida, 2010, Depression, antidepressant use and mortality in later life: the health in men study, PLoS One, 5, e11266, 10.1371/journal.pone.0011266 · DOI
- Borhani, 1991, Systolic Hypertension in the Elderly Program (SHEP). Part 1: rationale and design, Hypertension, 17, II2, 10.1161/01.HYP.17.3_Suppl.II2 · DOI
- Butters, 2008, Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B, Alzheimer Disease and Associated Disorders, 22, 261, 10.1097/WAD.0b013e31816c92bf · DOI
- Culang, 2009, Change in cognitive functioning following acute antidepressant treatment in late-life depression, American Journal of Geriatric Psychiatry, 17, 881, 10.1097/JGP.0b013e3181b4bf4a · DOI · Paper page
- Goveas, 2011, Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study, Journal of the American Geriatric Society, 59, 57, 10.1111/j.1532-5415.2010.03233.x · DOI
- Haney, 2010, Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?, Bone, 46, 13, 10.1016/j.bone.2009.07.083 · DOI
- Hashioka, 2009, Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease, Central Nervous System Agents in Medicinal Chemistry, 9, 12, 10.2174/187152409787601897 · DOI
- Irie, 2008, Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study, Archives of General Psychiatry, 65, 906, 10.1001/archpsyc.65.8.906 · DOI
- Knegtering, 1994, Effects of antidepressants on cognitive functioning of elderly patients. A review, Drugs and Aging, 5, 192, 10.2165/00002512-199405030-00005 · DOI
- Lee, 2007, Persistent mild cognitive impairment in geriatric depression, International Psychogeriatrics, 19, 125, 10.1017/S1041610206003607 · DOI
- Mark, 2011, Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costs, American Journal of Geriatric Psychiatry, 19, 211, 10.1097/JGP.0b013e3181f1803d · DOI
- Mossello, 2008, Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease, Dementia and Geriatric Cognitive Disorders, 25, 372, 10.1159/000121334 · DOI · Paper page
- Ownby, 2006, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis, Archives of General Psychiatry, 63, 530, 10.1001/archpsyc.63.5.530 · DOI · Paper page
- Rajji, 2008, Use of antidepressants in late-life depression, Drugs and Aging, 25, 841, 10.2165/00002512-200825100-00003 · DOI
- Ravaglia, 2008, Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort, American Journal of Geriatric Psychiatry, 16, 834, 10.1097/JGP.0b013e318181f9b1 · DOI
- Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 · DOI · Paper page
- Sapolsky, 2000, Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders, Archives of General Psychiatry, 57, 925, 10.1001/archpsyc.57.10.925 · DOI · Paper page
- Sheline, 2010, Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial, Archives of General Psychiatry, 67, 277, 10.1001/archgenpsychiatry.2009.204 · DOI · Paper page
- Shumaker, 1998, The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia, Controlled Clinical Trials, 19, 604, 10.1016/S0197-2456(98)00038-5 · DOI
- Shumaker, 2004, Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study, JAMA, 291, 2947, 10.1001/jama.291.24.2947 · DOI
- Smoller, 2009, Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study, Archives of Internal Medicine, 169, 2128, 10.1001/archinternmed.2009.436 · DOI
- Steffens, 2000, Hippocampal volume in geriatric depression, Biological Psychiatry, 48, 301, 10.1016/S0006-3223(00)00829-5 · DOI
- Steffens, 2004, Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study, Journal of Geriatric Psychiatry and Neurology, 17, 202, 10.1177/0891988704269819 · DOI · Paper page
- Steffens, 2008, Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study, Stroke, 39, 857, 10.1161/STROKEAHA.107.498097 · DOI
- Tuunainen, 2001, Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview, Psychiatry Research, 103, 261, 10.1016/S0165-1781(01)00278-5 · DOI
- Weintraub, 2010, Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes, American Journal of Geriatric Psychiatry, 18, 332, 10.1097/JGP.0b013e3181cc0333 · DOI
- Wright, 2009, Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study, Journal of the American Geriatric Society, 57, 243, 10.1111/j.1532-5415.2008.02127.x · DOI
Cited by
Sorted by citations
Chan, J. Y. C., Yiu, K. K. L., Kwok, T. C. Y., Wong, S. Y. S., & Tsoi, K. K. F. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.12.004 · Cited by 135
Antidepressant use and cognitive decline in patients with dementia: a national cohort study
Mo, M., Abzhandadze, T., Hoang, M. T., Sacuiu, S., Jurado, P. G., Pereira, J. B., Naia, L., Kele, J., Maioli, S., Xu, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03851-3 · Cited by 45
Huang, I.-C., Chang, T.-S., Chen, C., & Sung, J.-Y. (2022) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac054 · Cited by 41
Wang, G. H.-M., Li, P., Wang, Y., Guo, J., Wilson, D. L., & Lo-Ciganic, W.-H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196342 · Cited by 23
Wang, G. H.-M., Chen, W.-H., Chang, S.-H., Zhang, T., Shao, H., Guo, J., & Lo-Ciganic, W.-H. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04475-z · Cited by 13
Risk of dementia among antidepressant elderly users: A population-based cohort analysis in Spain
Santandreu, J., Caballero, F. F., Gómez-Serranillos, M. P., & González-Burgos, E. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.002 · Cited by 3
Metadata
- Authors
- Goveas, J. S., Hogan, P. E., Kotchen, J. M., Smoller, J. W., Denburg, N. L., Manson, J. E., Tummala, A., Mysiw, W. J., Ockene, J. K., Woods, N. F., Espeland, M. A., & Wassertheil-Smoller, S.
- Affiliations
- Medical College of Wisconsin (US)
- Wake Forest University Health Sciences (US)
- Massachusetts General Hospital (US)
- University of Iowa (US)
- Brigham and Women's Hospital (US)
- The Ohio State University Wexner Medical Center (US)
- University of Massachusetts Chan Medical School (US)
- University of Washington (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Goveas, Joseph S.
- ORCID
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 24
- Issue
- 8
- Pages
- 1252-1264
- ISSN
- 1041-6102 (ISSN-L)
- PMC
- PMC5800401
- OpenAlex
- W2039400277
- Cited by
- 54
- References
- 7
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (n01wh32105-27-0-1, n01wh32108-30-0-1, n01wh32112-26-0-1, n01wh32100-28-0-1, n01wh32118-27-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, n01wh22110-38-0-0, N01-WH-3-2115, N01WH24152, N01 WH024152, n01wh24152-12-0-0, n01wh32122-31-0-1, n01wh32119-24-0-1, N01-WH-3-2122, N01-WH-32108-9, N01WH 32111-13, N01 WH 32105-6, N01 WH032108, N01 WH022110, N01 WH032105, N01-WH-32100-2, N01 WH032118, N01 WH032115, N01 WH032119, N01WH 32118-32119, N01 WH032111, N01 WH032112)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- antidepressant use, depressive symptoms, mild cognitive impairment, dementia, postmenopausal women, selective serotonin reuptake inhibitors, tricyclic antidepressants, geriatric depression, cognitive aging, Women's Health Initiative Memory Study
- MeSH terms
- Aged, Antidepressive Agents, Climacteric, Cross-Sectional Studies, Dementia, Depressive Disorder, Female, Follow-Up Studies, Health Surveys, Humans, Prospective Studies, Risk Factors, United States, Cohort Studies, Comorbidity, Estrogen Replacement Therapy, Incidence, Proportional Hazards Models, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review